Holen Sie sich die Stockscreener-App
1.098
2.86%
0.048
Schlusskurs vom Vortag:
$1.05
Offen:
$1.01
24-Stunden-Volumen:
252.02K
Relative Volume:
0.13
Marktkapitalisierung:
$2.50M
Einnahmen:
$8.27M
Nettoeinkommen (Verlust:
$-17.52M
KGV:
-0.0175
EPS:
-62.6089
Netto-Cashflow:
$-10.90M
1W Leistung:
-1.82%
1M Leistung:
-28.48%
6M Leistung:
-67.76%
1J Leistung:
+14.89%
1-Tages-Spanne:
$0.995
$1.12
1-Wochen-Bereich:
$0.9934
$1.1936
52-Wochen-Spanne:
$0.19
$25.95
Nuwellis Inc Stock (NUWE) Company Profile
Firmenname
Nuwellis Inc
Sektor
Branche
Telefon
952-345-4200
Adresse
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Compare NUWE vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
1.08 | 2.43M | 8.27M | -17.52M | -10.90M | -62.61 |
ABT
Abbott Laboratories
|
102.40 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.79 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.51 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.40 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
79.87 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Eingeleitet | ROTH MKM | Buy |
Nuwellis Inc Aktie (NUWE) Neueste Nachrichten
In fiscal year 2025, the pediatric business segment under Nuwellis, Inc. demonstrated strong growth, with its sales revenue in the U.S. market approaching 50% of the company's total domestic revenue. - Bitget
Nuwellis reports pediatric segment reaches 50% of U.S. revenue By Investing.com - in.investing.com
Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone - Bitget
Nuwellis Pediatric Category Achieves Approximately 50% Of Total U.S. Revenue In 2025, Marking Growth Milestone - TradingView
Half of Nuwellis U.S. revenue now comes from pediatric care - stocktitan.net
Macro Review: Is Nuwellis Inc forming a breakout pattern2026 Momentum & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Nuwellis (LTS:0HQX) PE Ratio : N/A (As of Mar. 28, 2026) - gurufocus.com
Nuwellis announces resignations of two board members and reduces board size - Investing.com UK
Nuwellis Board Directors Resign Amid Governance Dispute - TipRanks
[8-K] Nuwellis, Inc. Reports Material Event - stocktitan.net
Nuwellis Inc (NUWE) Stock Price & 30 Year Financial Data - gurufocus.com
Risk Report: What is Nuwellis Incs 5 year growth outlook2026 Setups & Long-Term Capital Growth Ideas - baoquankhu1.vn
Nuwellis signs letter of intent to acquire Rendiatech - MSN
Investment Report: Does Nuwellis Inc have pricing power2026 EndofYear Setup & Long-Term Safe Return Strategies - baoquankhu1.vn
Nuwellis (NASDAQ: NUWE) director Emerson Martin J submits initial Form 3 - Stock Titan
Nuwellis Completes Acquisition of Kidney Monitoring Innovator Rendiatech - The Globe and Mail
Nuwellis completes acquisition of Rendiatech for renal monitoring By Investing.com - za.investing.com
CEO Moves: How correlated is VIVK to the S P5002026 Closing Moves & High Accuracy Buy Signal Tips - baoquankhu1.vn
NUWE SEC FilingsNuwellis Inc 10-K, 10-Q, 8-K Forms - stocktitan.net
Nuwellis, Inc. completed the acquisition of Rendiatech Ltd. - marketscreener.com
Nuwellis completes acquisition of Rendiatech for renal monitoring - Investing.com
Nuwellis completes acquisition of Rendiatech, expanding technology portfolio - Investing.com
Nuwellis, Inc. Completes Acquisition of Rendiatech, Expanding Automated Kidney Monitoring Technology Portfolio - Minichart
Nuwellis (NUWE) Finalizes Acquisition of Israeli Tech Firm Rendi - gurufocus.com
Nuwellis Completes Acquisition of Rendiatech - Bitget
Nuwellis (NASDAQ: NUWE) closes deal for Rendiatech kidney monitoring tech - Stock Titan
Nuwellis buys new kidney monitors to guide earlier care for sickest patients - Stock Titan
Nuwellis, Inc. (NASDAQ: NUWE) Q4 2025 earnings call transcript - MSN
Nuwellis (NUWE) Q4 2025 Earnings Call Transcript - AOL.com
Nuwellis, Inc. 2026 Annual Report: Aquadex System Market, Risks, and Regulatory Overview - Minichart
Nuwellis Q4 Earnings Call Highlights - Defense World
Nuwellis 10-K: $8.27M Revenue, $(25.39) Loss Per Share - TradingView
Nuwellis, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Nuwellis Inc (NUWE) Reports Q4 Earnings - AlphaStreet
Nuwellis Earnings Call: Margin Gains Amid Cash Strain - TipRanks
Earnings call transcript: Nuwellis Q4 2025 sees strategic shifts amid revenue growth - Investing.com Nigeria
Earnings call transcript: Nuwellis Q4 2025 sees strategic shifts amid revenue growth By Investing.com - Investing.com South Africa
Nuwellis (NUWE) Q4 2025 revenue rises 4% as yearly loss widens - Stock Titan
Nuwellis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Nuwellis (NUWE) Reports Increased Q4 Revenue Amidst Strategic Re - GuruFocus
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results - Bitget
BRIEF-Nuwellis Q4 EPS USD -1.5 - TradingView
Nuwellis Q4 2025 Earnings Call Transcript - MarketBeat
Nuwellis Earnings Preview - Benzinga
Nuwellis Inc expected to post a loss of $1.56 a shareEarnings Preview - TradingView
Nuwellis appoints Stuart Goldstein as clinical strategy director By Investing.com - Investing.com Canada
Finanzdaten der Nuwellis Inc-Aktie (NUWE)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):